Recent Press Releases

Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix

Editor Note: For more information about this release, please scroll to bottom.

LONDON, February 2, 2015

Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER

Zohydro ER With BeadTek(TM) to be Available in the Second Quarter of 2015 SAN DIEGO, Jan. 30, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing and commercializing...

Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

Lexington, MA – January 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine dimesylate)...

Merck Repatriates Diabetes and Thyroids Portfolio in Russia to Continue to Drive Emerging Markets Strategy

Move transfers responsibility from marketing partner Takeda to Merck Serono for products in diabetes and thyroid franchises in Russia Transaction reflects company focus on further expansion in...

PREZCOBIX(TM) (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1

Combined Fixed-Dose Tablet of Darunavir and Cobicistat Can Help Reduce Number of Pills in a Combination Antiretroviral Treatment Regimen TITUSVILLE, NJ, January 29, 2015 - Janssen Therapeutics,...

Theravance Biopharma, Inc. and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD

Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015 GEORGE TOWN, Grand Cayman and PITTSBURGH, Feb. 2, 2015 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) and Mylan...

Mylan to Acquire Famy Care Businesses to Create a Leading Women's Health Care Franchise

Mylan to Acquire Famy Care Businesses to Create a Leading Women's Health Care Franchise Expected to be immediately accretive to Mylan's adjusted diluted earnings per share upon closing...

Alcon receives FDA approval of Pazeo(TM) Solution for ocular allergy itch relief

US Food and Drug Administration grants approval of Pazeo(TM) (olopatadine hydrochloride ophthalmic solution) 0.7% for sale in the United States Developed with efficacy data at 24 hours, post dose, to...

FDA expands approved use of Imbruvica for rare form of non-Hodgkin lymphoma

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) for patients with Waldenström's macroglobulinemia (WM), a rare form of cancer that begins in the...

Valeant Selected As Lead Bidder To Acquire Dendreon And Its Leading Immunotherapy Treatment, PROVENGE® (sipuleucel-T)

01/29/2015 LAVAL, Quebec, Jan. 29, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has entered into a "stalking horse"...

VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile Dysfunction Treatment Approved in Europe to Be Taken Approximately 15 Minutes Before Sexual Activity

VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile Dysfunction Treatment Approved in Europe to Be Taken Approximately 15 Minutes Before Sexual...

AbbVie Reports Fourth-Quarter and Full-Year 2014 Financial Results

AbbVie Reports Fourth-Quarter and Full-Year 2014 Financial Results - Reports Full-Year Adjusted EPS of $3.32, Up 5.7 Percent; GAAP EPS $1.10 - Delivers Fourth-Quarter Adjusted Revenue of $5.371...

Lilly Reports Fourth-Quarter and Full-Year 2014 Results, Updates 2015 Guidance

INDIANAPOLIS, Jan. 30, 2015 /PRNewswire/ -- Fourth-quarter 2014 revenue declined 12 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista and the unfavorable impact of...

Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia

FIND FH Initiative Unites Industry, Advocacy Community and Academia in an Effort to Support People Affected by Familial Hypercholesterolemia (FH), a Serious Genetic Disorder

Abbott Reports Fourth-Quarter 2014 Results

- Fourth-Quarter EPS Above Previous Guidance Range, Including Results From Discontinued Operations -

ABBOTT PARK, Ill., Jan.

Celgene Reports Fourth Quarter and Full Year 2014 Operating and Financial Results

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) reported operating results for the fourth quarter and full year of 2014. For the fourth quarter of 2014, net product sales were...

AMERICANS FACED DOUBLE DIGIT INCREASES IN PRESCRIPTION DRUG PRICES IN 2014, ACCORDING TO TRUVERIS NATIONAL DRUG INDEX SM

AMERICANS FACED DOUBLE DIGIT INCREASES IN PRESCRIPTION DRUG PRICES IN 2014, ACCORDING TO TRUVERIS NATIONAL DRUG INDEX SM Branded Drugs Jump 15%, Specialty Drugs Rise 10%, Generics Up 5% NEW...

Salix Provides Update on Audit Committee Review

Audit Committee Determines to Restate Financial Statements for FY2013 and First Three Quarters of 2014 *Aggregate impact of errors on net product revenue and net income over all previously...